Molecule Details
| InChIKey | ZBIAKUMOEKILTF-UHFFFAOYSA-N |
|---|---|
| Compound Name | Lidoflazine |
| Canonical SMILES | Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.17 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13766 |
|---|---|
| Drug Name | Lidoflazine |
| CAS Number | 3416-26-0 |
| Groups | approved |
| ATC Codes | C08EX01 |
| Description | nan |
Categories: Agents causing hyperkalemia Antiarrhythmic agents Bradycardia-Causing Agents Calcium Channel Blockers Calcium-Regulating Hormones and Agents Cardiovascular Agents Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Membrane Transport Modulators Negative Inotrope Non-Selective Calcium Channel Blockers Piperazines Potential QTc-Prolonging Agents QTc Prolonging Agents Vasodilating Agents
Cross-references: BindingDB: 23619 ChEBI: 93095 CHEMBL92870 ChemSpider: 3789 PharmGKB: PA165818137 RxCUI: 6390 Wikipedia: Lidoflazine ZINC: ZINC000022034381